Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03076827
Other study ID # Chuncheon201701
Secondary ID
Status Completed
Phase N/A
First received January 30, 2017
Last updated November 9, 2017
Start date October 2015
Est. completion date October 2016

Study information

Verified date November 2017
Source Chuncheon Sacred Heart Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Cortisol is a hormone that increases after trauma or surgery and has circadian rhythm. It has a form that is increased in the morning and decreased in the evening. The investigators expected to be influenced by circadian rhythm according to the time of operation, and compared morning and afternoon surgery.


Description:

44 patients to undergo hip hemiarthroplasty or total hip replacement were divided to morning surgery group(Group A) and afternoon surgery group(Group P). All surgery was done by the same orthopedic surgeon. Anesthesia of Group A was started at 8 a.m. and Group P was at 12~2 p.m. Blood sampling was performed at 7:30 a.m., after induction of anesthesia, 6, 12, 24 and 48 hours after surgery in all patients of both groups. Cortisol, IL-6, and IL-8 was measured immediately after blood sampling. Visual analogue scale(VAS) was used to assess the degree of pain at before start of anesthesia, 6, 12, 24 and 48 hours after surgery. The postoperative hospital stay was calculated. Postoperative management was done by the same management team. Surgical wounds were treated at the same 24 hour intervals.

A sample size was calculated to differentiate between groups. Because difference of cortisol according to groups in ANOVA based on pilot study, the sample size was 20 patients per group. (Effect size f(v)= 0.5297047, α=0.05, 1-β=0.90) The investigators recruited total 44 patients to cover dropout 10%.


Recruitment information / eligibility

Status Completed
Enrollment 44
Est. completion date October 2016
Est. primary completion date October 2016
Accepts healthy volunteers No
Gender All
Age group 20 Years to 100 Years
Eligibility Inclusion Criteria:

- Patients scheduled for hip hemiarthroplasty

- Patients scheduled for total hip replacement

Exclusion Criteria:

- Sleep disorder

- Mental disorder

- Psychiatric medication

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Total hip replacement
Total hip replacement starts in the morning in group A and starts in the afternoon in group P.
Hemi-arthroplasty
Hemi-arthroplasty starts in the morning in group A and starts in the afternoon in group P.

Locations

Country Name City State
n/a

Sponsors (1)

Lead Sponsor Collaborator
Chuncheon Sacred Heart Hospital

References & Publications (1)

Popma A, Doreleijers TA, Jansen LM, Van Goozen SH, Van Engeland H, Vermeiren R. The diurnal cortisol cycle in delinquent male adolescents and normal controls. Neuropsychopharmacology. 2007 Jul;32(7):1622-8. Epub 2007 Jan 17. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Cortisol level Cortisol levels over time within the first 2 days after surgery
Secondary Interleukin-6 Interleukin-6 levels over time within the first 2 days after surgery
Secondary Interleukin-8 Interleukin-8 levels over time within the first 2 days after surgery
Secondary Visual analogue scale pain scale over time within the first 2 days after surgery
Secondary Post-operative hospital stay Hospital day after surgery. Hospital day after surgery.
See also
  Status Clinical Trial Phase
Active, not recruiting NCT05666479 - CGM Monitoring in T2DM Patients Undergoing Orthopaedic Replacement Surgery
Recruiting NCT03746925 - Comparing Short-term Outcomes After Direct Anterior and SuperPATH Hip Arthroplasty Approaches N/A
Completed NCT03008967 - A Study of Patients Undergoing Total Knee and Hip Arthroplasty at a Regional Hospital in Denmark N/A
Not yet recruiting NCT00958945 - Retrospective Chart Analysis in the Effective Use of FloSeal in Post-Operative Joint Replacements N/A
Completed NCT00980616 - Use of Local Analgesia With Epinephrine During Total Hip Arthroplasty (THA) Phase 2
Completed NCT04542174 - PMCF 8 Year Results TRJ®
Not yet recruiting NCT04019925 - Assessing the Wear Rates of the ADM/MDM Hips Using 3D X-ray Analysis N/A
Recruiting NCT06102811 - Low Concentration Local Anesthesia Fascia Iliaca Block for Total Hip Arthroplasty N/A
Recruiting NCT03570944 - Postoperative Outcomes Within an Enhanced Recovery After Surgery Protocol (POWER2)
Recruiting NCT02938962 - Intravenous vs. Topical Tranexamic Acid in Revision THA (VITALITY-X) Phase 4
Recruiting NCT02385383 - An Intravenous Iron Based Protocol for Preoperative Anaemia in Hip and Knee Surgery - An Observational Study N/A
Completed NCT01444586 - Russian Non-Interventional Study on Compliance of Venous Thromboembolism (VTE) N/A
Terminated NCT02525627 - A Comparative Study of In-vivo Wear Between 28 mm and 40 mm Metal Heads N/A
Completed NCT00808483 - Walking Skill Training Program Effects in Patients With Total Hip Arthroplasty N/A
Terminated NCT00958347 - Omnifit Hydroxylapatite (HA) Hip Outcomes Study N/A
Completed NCT01422304 - Reversal of Neuromuscular Blockade With Sugammadex or Usual Care in Hip Fracture Surgery or Joint (Hip/Knee) Replacement (P07038) Phase 3
Completed NCT04332055 - RCT Measuring the Effect of the ERVIN Software N/A
Completed NCT01257568 - Rejuvenate Modular Outcomes Study N/A
Recruiting NCT01031732 - Evaluation of Four Surgical Techniques in Primary Total Hip Arthroplasty N/A
Completed NCT00797264 - Ketamine Associated With Morphine PCA After Total Hip Arthroplasty N/A